Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain
PALO ALTO, Calif., Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- Scilex Holding Company ( Nasdaq: SCLX, "Scilex" or "Company" ) , an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, ...
| Ticker |
Sentiment |
Impact |
|
DECA
|
Neutral
|
2 %
|
|
SCLX
|
Neutral
|
45 %
|
